ATA. A. Tarkhanova

A. A. Tarkhanova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


A. A. Tarkhanova has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Results of Observational Study and Integration of Epinastine 0,05% in Treatment Algorythms of Patients with Seasonal Allergic Conjunctivitis

    by D. Yu. Maychuk, E. A. Drozdova, A. A. Tarkhanova, E. E. Zinych, Д. Ю. Майчук

    Objective. To assess tolerability and the time of onset of clinical effect of dual­-action antihistamine agents — Epinepta® (epinastine 0.05 %) and olopatadine 0.1 % in patients with seasonal allergic conjunctivitis (SAC).Subjects and methods. This was a prospective multicenter observational study. One hundred fifty patients with SAC (n = 150) were included into the study and divided into two groups (n = 75) in each. Patients in group 1 received epinastine 0.05 %, while patients into group 2 received olopatadine 0.1 %. Evaluation of clinical symptoms severity was performed using itching scale, hyperemia Efrone scale, eyelid swelling scale, lacrimation P. Munk scale, Shirmer test and Norn probe. Patients and healthcare providers satisfaction rate was assessed by Likert scale, patients self-­control diary that helped to assess dry eye severity symptoms. Treatment period lasted 14 days.Results. Seasonal allergic conjunctivitis treatment with epinastine 0.05 % or olopatadine 0.1 % was equally effective. However epinastine 0.05 % was causing dry eye symptoms in lesser degree than olopatadine 0.1 %. These results refer to all parameters assessed by patients’ self­-control diary — itching, discomfort, burning, eye blockage feeling.Conclusion. The study evaluated epinastine 0.05 % advantages compared to olopatadine 0.1 % in tear film preservation and causing less pronounced symptoms of dry eye in patients with acute seasonal allergic conjunctivitis. Monotherapy of seasonal allergic conjunctivitis with epinastine 0.05 % demonstrated high efficacy and lead to SAC clinical manifestations regress. Epinastine 0.05 % is recommended as a first line treatment of SAC.


  • Open Access

    Recurrent Betaherpetic Keratitis. Therapy Stages and Monitoring Methods of the Disease Dynamics

    by D. Yu. Maychuk, A. A. Tarkhanova, M. R. Taevere, Д. Ю. Майчук

    Purpose: to propose a step­by­step treatment regimen for betaherpetic keratitis with a method for monitoring the dynamics of the disease.Patients and methods. The study group included 40 patients (40 eyes). Each patient had a history of diagnosed unilateral recurrent acute or subacute keratitis, the etiology of the betaherpetic process was confirmed by laboratory diagnostic methods, confocal microscopy, based on the detection of specific “owl eye” cells. All subjects had previously received specific therapy with acyclovir. All patients underwent an ophthalmological examination, and then a two­stage treatment regimen for keratitis was proposed. The main way to assess the dynamics of the disease, the presence of viral load and the need to intensify antiviral therapy was confocal microscopy data. The condition was assessed 1, 3, 6 and 12 months after the start of therapy. Results. As a result of the observation of a group of patients of 40 people, after 12 months, 33 patients achieved stable remission, 4 patients developed neurotrophic keratitis, and 3 patients had a relapse of betaherpetic keratitis. Recurrence of keratitis in 3 patients was detected within 2 to 4 months from the start of observation. Neurotrophic keratitis developed in 4 patients within 3 to 6 months from the start of observation.Conclusion. 1) The method of in vivo confocal microscopy can be used to monitor the dynamics of betaherpetic keratitis, based on the state of specific cells. 2) Therapy of betaherpetic keratitis requires the use of specific antiviral drugs with mandatory repeated preventive courses. 3) A history of herpesvirus infection requires assessment of the development of neurotrophic keratitis.

  • Subfamily of betaherpesviruses as a cause of epithelial and stromal keratitis

    by D.YU. Maychuk, A.A. Tarkhanova, M.R. Taevere, A.V. Shatskih, S.A. Sudakova

    Purpose. This article presents the first clinical results of intravital morphological verification of epithelial and stromal keratitis associated with betaherpesviruses. Material and methods. The study group included 12 patients (12 eyes) diagnosed with herpetic keratitis. During the initial visit to the clinic, each patient underwent a standard ophthalmological examination, as well as a number of laboratory tests: immunochemical analysis of blood, molecular diagnostics, and confocal microscopy. Histological study of the cornea was additionally performed in cases indicated for surgical treatment (2 patients). Results. According to enzyme-linked immunoelectrodiffusion essay (ELISA), acute-phase immunoglobulins of class M (Ig M) to cytomegalovirus (CMV) were detected in only one clinical case. Class G immunoglobulins (Ig G) to both CMV and human herpes virus type 6 (HHV-6) were detected in the majority of cases. Quantitative polymerase chain reaction (qPCR) revealed CMV DNA in tears (2 patients) and in saliva (4 patients). The HHV-6 genome was found in tears (2 patients) and in saliva (3 patients). According to the results of confocal microscopy, owl’s eye cells were found in 8 patients of the group. Histological examination of the cornea helped identify pathognomonic cells in one case. Thus, 8 patients of the group were diagnosed with keratitis associated with the betaherpesvirus subfamily. Conclusion. Results of observation of the study patients suggest the possibility of developing keratitis associated with the subfamily of betaherpesviruses with localization in the superficial layers of the cornea. Confocal microscopy can be useful for identification of pathognomonic owl’s eye cells in the corneal tissues and confirmation of the diagnosis of betaherpesvirus-associated keratitis. Investigation of the etiological factor of superficial and stromal viral keratitis is important for determining the further tactics of pharmacotherapy.


  • Betaherpetic keratitis. Substantiation of diagnosis and patient management tactics

    by Moscow S. Fyodorov Eye Microsurgery Federal State Institution, A.A. Tarkhanova, D.Y. Maychuk, E.е. Zinych, M.R. Taevere

    Relevance. This publication presents an algorithm for the management of patients with recurrent keratitis associated with betaherpesviruses and outlines the possibilities of laboratory and instrumental diagnostics. Purpose. To systemize the algorithm for the management of patients with superficial keratitis associated with betaherpesviruses confirmed by confocal microscopy. Material and methods. A group of 21 patient (21 eye) with superficial keratitis associated with betaherpesviruses was under observation during 12 months. The diagnosis was made on the basis of confocal microscopy results, clinical picture and results of laboratory tests. Each patient received a two-stage treatment with nucleoside analogues locally and systemically; treatment with anti-inflammatory and reparative medicine. Results. Remission as a result of the treatment was achieved in 20 of the 21 patients. Conclusion.The only reliable diagnostic method of keratitis associated with betaherpesviruses is a confocal microscopy, with identification of betaherpesvirus specific «owl's eye» cells. In view of frequent recurrence leading to increase of cornea opacity area, therapy of keratitis associated with betaherpesviruses requires a two-stage treatment. In first stage it is mandatory to prescribe increased dosages of nucleoside analogues, second stage requires prescription of local glucocorticoids and long-term reparative treatment. Key words: keratitis, herpesviruses, cytomegalovirus, human herpesvirus 6, «owl's eye» cells


  • Method for the treatment of recurrent herpetic keratitis based on lamellar keratoplasty assisted by a femtosecond laser (сase series)

    by Moscow The S. Fyodorov Eye Microsurgery Federal State Institution, S.B. Izmailova, D.Y. Maychuk, L.L. Arutyunyan, A.A. Tarkhanova, A.Z. Zyganov, L.S. Maksudova

    Purpose. To evaluate the clinical efficacy of lamellar keratoplasty in the treatment of recurrent herpetic keratitis with femtosecond laser-assisted corneal surgery. Material and methods. In two clinical cases, lamellar keratoplasty with femtosecond laser-assisted corneal surgery was performed. Preoperative and postoperative visual acuity, refractometry, keratotopography, pachymetry were examined. Conducted courses of conservative treatment: antiviral, anti-inflammatory, desensitization therapy using vaccination «Vitogerpavak». Results. Evidence of the effectiveness of the proposed method was obtained - stabilization and relief of the inflammatory process, increased visual acuity and cosmetic effect. Conclusion. Cases of successful treatment of recurrent herpetic keratitis after intensive courses of conservative treatment followed by lamellar keratoplasty with femtosecond laser-assisted surgery are presented. The use of femtolaser technologies, which allow dosed excision of the affected tissue at a certain depth according to predetermined parameters, contributes to the achievement of high functional results. Lamellar keratoplasty with the maximum possible excision of scar tissue and its replacement with a donor cornea is a minimally invasive effective method to restore the transparency of the cornea after therapeutic treatment of recurrent herpetic keratitis. Key words: keratoplasty, herpetic keratitis, femtosecond laser

  • Ophthalmic products with extracellular matrix components. Their effectiveness in the process of corneal repair in neurotrophic, herpetic, recurrent keratitis and erosions

    by Moscow Fyodorov Eye Microsurgery Federal State Institution, D.Y. Maychuk, A.A. Tarkhanova, I.A. Pronkin

    Introduction. One of the topical issues of modern ophthalmology is the widespread prevalence of corneal blindness among the working-age population. The cause of this condition in most cases are infectious and inflammatory diseases of the anterior segment of the eye, the outcome of which is a violation of the architectonics of the extracellular matrix (ECM) of the cornea, clinically manifested by edema of the stroma, its fibrosis. Purpose. Comparative analysis of the effectiveness of existing ophthalmic agents based on biomimetics of ECM to stimulate the processes of reparative regeneration in neurotrophic, herpetic, recurrent keratitis and corneal erosions. Material and methods. Our literature review has shown the great importance of the components in maintaining corneal homeostasis, its transparency, strength, shape stability, as well as differentiation, proliferation, migration and growth of cellular structures of the ECM, and therefore the need to maintain its physiological architectonics in the treatment of infectious and inflammatory pathology. Results. The range of ophthalmic medicines and medical devices based on biomimetics of ECM is quite diverse. The active substances of such ophthalmic agents are the main components of the ECM, namely, glycosaminoglycans (GAG), glycoproteins, collagen, hyaluronic acid, heparin. Conclusion. Among the many biomimetics, we can single out the multicomponent hydrogel composition «Corneal Epithelium gel Protector (CEGP) SPHERO ® oko (JSC «BIOMIR Service», Russia), designed to restore the corneal epithelium, which includes both the main components of ECM and other biologically active substances, including peptides, amino acids, uronic acids, monosaccharides, growth factors, etc. The multicomponent composition of SPHERO ® oko provides the microenvironment necessary for the cells of the eye tissues, contributing to the processes of their proliferation and differentiation and, as a final result, to the acceleration of reparative regeneration of tissues damaged as a result of injury or infectious-inflammatory process. And also SPHERO ® oko demonstrates anti-inflammatory, decongestant, tear-substituting action, contributes to reducing neovascularization. Key words: SPHERO ® oko, extracellular matrix, keratitis, erosion, herpes, dry eye disease, cornea